Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Strengthening National Capacity in Malaria and Other Infectious Disease Operations Research, Funding Opportunity Announcement (FOA), CK09-004, Initial Review, 25561 [E9-12328]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 101 / Thursday, May 28, 2009 / Notices
• Audit Requirements: OMB Circular
A–133, ‘‘Audits of States, Local
Governments, and Non-Profit
Organizations.’’
3. Indirect Costs
This section applies to indirect costs
in accordance with HHS Grants Policy
Statement, Part II–27. The IHS requires
applicants to have a current indirect
cost rate agreement in place prior to
award. The rate agreement must be
prepared in accordance with the
applicable cost principles and guidance
as provided by the cognizant agency or
office. A current rate means the rate
covering the applicable activities and
the award budget period. If the current
rate is not on file with the awarding
office, the award shall include funds for
reimbursement of indirect costs.
However, the indirect costs portion will
remain restricted until the current rate
is provided to the DGO.
If an urban Indian organization has
questions regarding the indirect costs
policy, please contact the DGO at (301)
443–5204.
4. Reporting
A. Progress Report. Program progress
reports on number of tests performed
and milestones are required quarterly by
the OUIHP in order to satisfy quarterly
reports due to funding source at MAI.
These reports will include a brief
comparison of actual accomplishments
to the goals established for the period,
reasons for unmet milestones (if
applicable), and other pertinent
information as required.
B. A Final Assessment and Evaluation
report must be submitted within 90 days
of expiration of the budget/project
period.
C. Financial Status Report. Semiannual financial status reports must be
submitted within 30 days of the end of
the half year. Final financial status
reports are due within 90 days of
expiration of the budget period.
Standard Form 269 (long form) will be
used for financial reporting.
D. Participation in a minimum of two
teleconferences. Teleconferences will be
required semi-annually (unless further
followup is needed) for Technical
Assistance and information to be
provided and progress to be shared
among grantees with the OUIHP and
National HIV Program Consultant.
Failure to submit required reports
within the time allowed may result in
suspension or termination of an active
agreement, withholding of additional
awards for the project, or other
enforcement actions such as
withholding of payments or converting
to the reimbursement method of
VerDate Nov<24>2008
17:11 May 27, 2009
Jkt 217001
payment. Continued failure to submit
required reports may result in one or
both of the following: (1) The
imposition of special award provisions;
and (2) the non-funding or non-award of
other eligible projects or activities. This
applies whether the delinquency is
attributable to the failure of the
organization or the individual
responsible for preparation of the
reports. Telecommunication for the
hearing impaired is available at: TTY
(301) 443–6394.
VII. Agency Contacts
For program-related and general
information regarding this
announcement: Danielle Steward,
Health Systems Specialist, Office of
Urban Indian Health Programs, 801
Thompson Avenue, Suite 200,
Rockville, MD 20852. (301) 443–4680 or
danielle.steward@ihs.gov.
For specific grant-related and
business management information:
Denise Clark, Senior Grants
Management Specialist, 801 Thompson
Avenue, TMP Suite 360, Rockville, MD
20852. (301) 443–5204 or
denise.clark@ihs.gov.
Dated: May 20, 2009.
Randy Grinnell,
Deputy Director for Management Operations,
Indian Health Service.
[FR Doc. E9–12318 Filed 5–27–09; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Strengthening
National Capacity in Malaria and Other
Infectious Disease Operations
Research, Funding Opportunity
Announcement (FOA), CK09–004,
Initial Review
June 1, 2009.
Correction: This notice was published
in the Federal Register on April 29,
2009, Volume 74, Number 81, page
19564. The original notice was
published with an incorrect FOA
number and incorrect date.
Contact Person for More Information:
Wendy Carr, PhD, Centers for Disease
Control and Prevention, 1600 Clifton
Road, NE., Mailstop D60, Atlanta, GA
30333. Telephone (404) 498–2276.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
25561
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: May 18, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–12328 Filed 5–27–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group, Motor Function, Speech and
Rehabilitation Study Section.
Date: June 8, 2009.
Time: 8 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Amalfi Hotel Chicago, 20 West
Kinzie Street, Chicago, IL 60654.
Contact Person: Biao Tian, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3166, MSC 7848, Bethesda, MD
20892. 301–402–4411. tianbi@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Epidemiology and
Population Studies Integrated Review Group,
Infectious Diseases, Reproductive Health,
Asthma and Pulmonary Conditions Study
Section.
Date: June 8–9, 2009.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Old Town Alexandria, 1767
King Street, Alexandria, VA 22314.
Contact Person: Sandra Melnick Seitz,
DRPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3156,
E:\FR\FM\28MYN1.SGM
28MYN1
]]>Agencies
[Federal Register Volume 74, Number 101 (Thursday, May 28, 2009)]
[Notices]
[Page 25561]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12328]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Strengthening National Capacity in Malaria and Other
Infectious Disease Operations Research, Funding Opportunity
Announcement (FOA), CK09-004, Initial Review
June 1, 2009.
Correction: This notice was published in the Federal Register on
April 29, 2009, Volume 74, Number 81, page 19564. The original notice
was published with an incorrect FOA number and incorrect date.
Contact Person for More Information: Wendy Carr, PhD, Centers for
Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop D60,
Atlanta, GA 30333. Telephone (404) 498-2276.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: May 18, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-12328 Filed 5-27-09; 8:45 am]
BILLING CODE 4163-18-P
